On November 23, 2022 Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, reported that members of the management team will present at the following upcoming investor conferences (Press release, Gamida Cell, NOV 23, 2022, View Source [SID1234624404]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

34th Annual Piper Sandler Healthcare Conference, November 29, 2022 with a fireside chat at 1:00 p.m. ET.
Evercore ISI Healthcare Conference, December 1, 2022 with a fireside chat at 2:15 p.m. ET.
A webcast of the event will be available on the "Investors & Media" section of Gamida Cell’s website at www.gamida-cell.com, and will be available for at least 14 days following the event.